| 4 |
| Capital Research Global Investors |
| 9.8M |
| $2.94B |
| +2.9% |
| 7.303% |
| 0.41% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 6.5M | $1.97B | +0.7% | 4.897% | 0.09% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 6.0M | $1.82B | +1.4% | 4.516% | 0.04% |
| 7 | Invesco Ltd. | 3.8M | $1.13B | +34.9% | 2.812% | 0.09% |
| 8 | STATE STREET CORP | 3.6M | $1.07B | +7.0% | 2.663% | 0.02% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.6M | $791.3M | -0.9% | 1.974% | 0.04% |
| 10 | JPMORGAN CHASE & CO | 2.7M | $785.3M | -57.7% | 2.004% | 0.04% |
| 11 | BAILLIE GIFFORD & CO | 2.4M | $734.5M | -2.2% | 1.827% | 0.67% |
| 12 | NORGES BANK | 2.3M | $683.9M | — | 1.702% | 0.07% |
| 13 | WELLINGTON MANAGEMENT GROUP LLP | 2.1M | $635.3M | +9.0% | 1.581% | 0.11% |
| 14 | Orbis Allan Gray Ltd | 2.0M | $598.3M | +48.9% | 1.489% | 2.06% |
| 15 | DODGE & COX | 2.0M | $588.6M | +1.4% | 1.465% | 0.31% |
| 16 | TWO SIGMA INVESTMENTS, LP | 1.9M | $564.7M | -5.9% | 1.405% | 0.41% |
| 17 | AMERICAN CENTURY COMPANIES INC | 1.9M | $558.1M | +2.9% | 1.389% | 0.25% |
| 18 | D. E. Shaw & Co., Inc. | 1.5M | $461.9M | +4.1% | 1.149% | 0.22% |
| 19 | Clearbridge Investments, LLC | 1.3M | $379.1M | -7.1% | 0.943% | 0.31% |
| 20 | MORGAN STANLEY | 1.0M | $310.7M | +2.9% | 0.773% | 0.02% |
| 21 | BANK OF AMERICA CORP /DE/ | 994K | $299.4M | +2.9% | 0.745% | 0.02% |
| 22 | Legal & General Group Plc | 925K | $278.3M | -1.1% | 0.693% | 0.06% |
| 23 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 894K | $269.1M | +34.9% | 0.669% | 0.10% |
| 24 | ROYAL BANK OF CANADA | 891K | $268.2M | +12.6% | 0.667% | 0.04% |
| 25 | NORTHERN TRUST CORP | 887K | $267.0M | +3.4% | 0.664% | 0.03% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in ALNY — a direct measure of their conviction.
| 99.05% |
| 1.46 pp |
| $31.66B |
| +13% |
| Q4 2024 | 569 | +5.6% | 100.51% | +4.02 pp | $27.91B | 11% |
| Q3 2024 | 539 | — | 96.49% | — | $31.48B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
ALNY institutional ownership rose by 2.44 percentage points quarter-over-quarter, with a net change of +4 holders.
The top 10 institutions account for 56.3% of all reported 13F value in ALNY, and the top 25 account for 74.2%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Alnylam Pharmaceuticals, Inc. (ALNY) Institutional Ownership